DYNAVAX TECHNOLOGIES news, videos and press releases
For more news please use our advanced search feature.
DYNAVAX TECHNOLOGIES - More news...
DYNAVAX TECHNOLOGIES - More news...
- Dynavax to Present at the 7th Annual Evercore HealthCONx Conference
- Dynavax Announces $100 Million Accelerated Share Repurchase Program
- Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates
- Dynavax Announces $200 Million Share Repurchase Program
- Dynavax Adopts Limited-Duration Stockholder Rights Plan
- Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024
- Dynavax Reports Second Quarter 2024 Financial Results and Provides Business Updates
- Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024
- Dynavax Initiates Phase 1/2 Study of Novel Shingles Vaccine Program
- Dynavax to Present at Upcoming Investor Conferences
- Dynavax Provides Regulatory Update on sBLA for Four-Dose HEPLISAV-B® Regimen for Adults on Hemodialysis in the U.S.
- Dynavax Reports First Quarter 2024 Financial Results and Provides Business Updates
- Dynavax to Report First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
- Dynavax Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Full Year 2024 Financial Guidance
- Dynavax to Report Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 22, 2024
- Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2023 Financial Highlights
- Dynavax to Present at the 42nd Annual J.P. Morgan Healthcare Conference
- Dynavax to Present at the 6th Annual Evercore ISI HealthCONx Conference
- Dynavax Reports Third Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
- Dynavax to Report Third Quarter 2023 Financial Results and Host Conference Call on November 2, 2023
- Dynavax to Present at the H.C. Wainwright 4th Annual Hepatitis B Virus Virtual Conference
- Dynavax to Present at the H.C. Wainwright 25th Annual Global Investment Conference
- Dynavax Reports Second Quarter 2023 Financial Results and Raises Full Year Revenue Guidance
- Dynavax to Report Second Quarter 2023 Financial Results and Host Conference Call on August 3, 2023
- Dynavax to Present at Upcoming Investor Conferences
- Dynavax to Present at the JMP Securities Life Sciences Conference
- Dynavax Reports First Quarter 2023 Financial Results
- Dynavax to Report First Quarter 2023 Financial Results and Host Conference Call on May 2, 2023
- Dynavax to Present at the Cowen 43rd Annual Health Care Conference
- Dynavax Announces Great Britain Marketing Authorization for HEPLISAV B®, a Two-Dose Adult Hepatitis B Adjuvanted Vaccine
